AUDIO: Commencing phase I trials in Israel can be started with short notice, as no licenses are needed. Phase II and III trials in Israel and globally require more planning and a longer timeline.
VIDEO: Identifying a partner with the relevant capabilities, expertise and experience to collaborate through this journey is a critical decision point for any company looking to outsource
AUDIO: With Direct-to-patient (DTP) protocols on the rise due to COVID, many sponsors are having to reconsider their returns & destruction strategy.
VIDEO: A clinical distribution plan must be solid enough to begin planning activities, and flexible enough to adapt to inevitable changes
VIDEO: Planning clinical trials requires an analysis of different possible scenarios and an objective assessment of clinical supply needs
ARTICLE: COVID-19 presented some unique challenges as we, like so many others, had to adjust to doing business in a virtual/digital world because of the new normal.
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Your bridge between life-changing therapies and patients